Press Releases
July 22, 2019
SBP Provides an Update on Ongoing Front-line Pancreatic Cancer Clinical Trial
- Preliminary Efficacy Signals Seen with SBP-101 Administered in Combination with Gemcitabine and Nab-paclitaxel
- DSMB Approves Enrollment of 3rd and Final Cohort